Legal & General Group
ALNA

Legal & General Group’s Allena Pharmaceuticals ALNA Stock Holding History

Legal & General Group’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,728
Closed -$7K – 3452
2019
Q2 		$7K Hold
1,728
– – ﹤0.01% 3425
2019
Q1 		$12K Hold
1,728
– – ﹤0.01% 3224
2018
Q4 		$9K Hold
1,728
– – ﹤0.01% 3283
2018
Q3 		$19K Hold
1,728
– – ﹤0.01% 3228
2018
Q2 		$23K Buy
1,728
+810
+88% +$11.7K ﹤0.01% 3142
2018
Q1 		$10K Hold
918
– – ﹤0.01% 3219
2017
Q4 		$9K Buy
+918
New +$11.3K ﹤0.01% 3242

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Legal & General Group's ALNA Position: Q3 2019 in Review

Legal & General Group sold out of Allena Pharmaceuticals (ALNA) in Q3 2019, closing a stake of 1,728 shares — an estimated $7K sold.

Legal & General Group first reported a position in ALNA in Q4 2017 and held it in 7 quarters. The position peaked at $23K in Q2 2018. 35 funds tracked by Wall St. Rank hold ALNA as of Q3 2019.

  • Legal & General Group reported no remaining Allena Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Legal & General Group sold 1,728 Allena Pharmaceuticals shares in Q3 2019, an estimated $7K.
  • Legal & General Group first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 7 quarters.
  • Legal & General Group's Allena Pharmaceuticals position peaked at $23K in Q2 2018.
  • 35 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.